Diagnosticos da America
R$3.95Change from previous close: −0.75%Absolute change: −R$0.03
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- R$4.91B
- Enterprise value
- R$11.65B
- Forward P/E
- 17.2
- PEG
- 0.64
- Price/book
- 0.72
- Price/sales
- 0.53
- EV/EBITDA
- 7.88
- EV/revenue
- 1.25
Profitability and growth
- Gross margin
- 31.0%
- Operating margin
- 10.8%
- Net margin
- -9.6%
- ROE
- -12.1%
- ROA
- 3.5%
- ROIC
- 7.8%
- Revenue growth (year over year)
- -9.8%
Financial health
- Total cash
- R$958.7M
- Total debt
- R$7.67B
- Debt/equity
- 1.12
- Current ratio
- 1.27
- Quick ratio
- 1.22
- Altman Z-Score
- 0.67
- Piotroski F-Score
- 5.00
Dividends
- Payout ratio
- 0.0%
- Ex-dividend date
- December 27, 2022
Analysts and estimates
- Average price target
- R$3.93
- Median price target
- R$4.00
- High price target
- R$5.00
- Low price target
- R$2.50
- Analysts with a price target
- 12
- Consensus
- Buy
- Forward EPS
- R$0.23
- EPS estimate, current year
- R$0.15
Shares and trading
- Beta
- 0.33
- Average volume
- 1.08M
- Shares outstanding
- 1.25B
- Float
- 1.18B
- Institutional ownership
- 87.0%
- Insider ownership
- 5.9%